Skip to Main content Skip to Navigation
Preprints, Working Papers, ...

The JAK2-STAT3 pathway controls a beneficial proteostasis response of reactive astrocytes in Huntington’s disease

Abstract : Huntington’s disease (HD) is a fatal neurodegenerative disease characterized by striatal neurodegeneration, aggregation of mutant Huntingtin (mHTT) and the presence of reactive astrocytes. Astrocytes are important partners for neurons and engage in a specific reactive response in HD that involves morphological, molecular and functional changes. How reactive astrocytes contribute to HD is still an open question, especially because their reactive state is poorly reproduced in mouse models. Here, we show that the JAK2-STAT3 pathway, a central cascade controlling the reactive response of astrocytes, is activated in the putamen of HD patients. Selective activation of this cascade in astrocytes reduces the number and size of neuronal mHTT aggregates and improves neuronal features in two HD mouse models. Moreover, activation of the JAK2-STAT3 pathway in astrocytes coordinates a transcriptional program that increases their intrinsic proteolytic capacity, through the lysosomes and the ubiquitin-proteasome system, and enhances their production of the co-chaperone DNAJB1, which is released in exosomes. Together, our results show that the JAK2-STAT3 pathway controls a beneficial proteostasis response in reactive astrocytes in HD, which involves bi-directional signalling with neurons to reduce mHTT aggregation and toxicity.
Document type :
Preprints, Working Papers, ...
Complete list of metadata

https://hal-cea.archives-ouvertes.fr/cea-03443773
Contributor : Carole Escartin Connect in order to contact the contributor
Submitted on : Tuesday, November 23, 2021 - 3:49:59 PM
Last modification on : Friday, November 26, 2021 - 3:43:26 AM

Licence


Distributed under a Creative Commons Attribution - NonCommercial - NoDerivatives 4.0 International License

Links full text

Identifiers

Collections

CEA | CNRS | ANR | DAMAS

Citation

L. Abjean, L. Ben Haim, M. Riquelme-Perez, P. Gipchtein, C. Derbois, et al.. The JAK2-STAT3 pathway controls a beneficial proteostasis response of reactive astrocytes in Huntington’s disease. 2021. ⟨cea-03443773⟩

Share

Metrics

Record views

10